Article Text

Download PDFPDF

Original article
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres
  1. A M Jones1,
  2. A D Beggs1,
  3. L Carvajal-Carmona1,
  4. S Farrington2,
  5. A Tenesa2,
  6. M Walker2,
  7. K Howarth1,
  8. S Ballereau2,
  9. S V Hodgson3,
  10. A Zauber4,
  11. M Bertagnolli5,
  12. R Midgley6,
  13. H Campbell7,
  14. D Kerr6,
  15. M G Dunlop2,
  16. I P M Tomlinson1
  1. 1Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
  2. 2Colon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and MRC Human Genetics Unit, Edinburgh, UK
  3. 3Department of Clinical Genetics, St George's Hospital Medical School, London, UK
  4. 4Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
  5. 5Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, Massachusetts, USA
  6. 6Department of Clinical Pharmacology, University of Oxford, Oxford, UK
  7. 7Public Health Sciences, University of Edinburgh, Edinburgh, UK
  1. Correspondence to Professor Ian Tomlinson, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK; iant{at}well.ox.ac.uk

Footnotes

  • Funding The Oxford group acknowledges funding from the EU FP7 CHIBCHA project, the Oxford Comprehensive Biomedical Research Centre and Cancer Research UK. The authors are also very grateful to Willem Ouwehand and colleagues for supplying the National Blood Service controls. The Edinburgh group were supported by grants from: Cancer Research UK (C348/A12076), Scottish Government Chief Scientist Office (K/OPR/2/2/D333), Medical Research Council (G0000657-53203) and a Centre Grant from CORE as part of the Digestive Cancer Campaign. Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford was provided by grant 090532/Z/09/Z.

  • Correction notice This article has been modified since it was published online first. The funding statement was corrected.

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Southampton and South-West Hampshire REC (A).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Supplementary materials

Footnotes

  • Funding The Oxford group acknowledges funding from the EU FP7 CHIBCHA project, the Oxford Comprehensive Biomedical Research Centre and Cancer Research UK. The authors are also very grateful to Willem Ouwehand and colleagues for supplying the National Blood Service controls. The Edinburgh group were supported by grants from: Cancer Research UK (C348/A12076), Scottish Government Chief Scientist Office (K/OPR/2/2/D333), Medical Research Council (G0000657-53203) and a Centre Grant from CORE as part of the Digestive Cancer Campaign. Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford was provided by grant 090532/Z/09/Z.

  • Correction notice This article has been modified since it was published online first. The funding statement was corrected.

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Southampton and South-West Hampshire REC (A).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Emad El-Omar William Grady Alexander Gerbes